The development of acute and chronic inflammatory processes induces, in the laboratory animal, a net accumulation of both copper and zinc in many body compartments, the inflammed area included. In rheumatoid arthritis, as well as in animal models, only plasma zinc concentration seems to be significantly correlated with disease severity, while the increase in total plasma copper could be described as an “all or nothing” phenomenon. Moreover, in rheumatoid arthritis, it appears that the disease develops and progresses without being linked to either copper or zinc deficiency conditions.
Thus, it seems reasonable to suggest that a rationale for the use of copper and/or zinc in the treatment of inflammatory disorders can only be drawn from the intrinsic pharmacological properties of such trace elements, rather than from the need for their repletion.
This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
This is the net price. Taxes to be calculated in checkout.
J. R. J. Sorenson,Copper complexes offer a physiological approach to treatment of chronic diseases. InProgress in Medicinal Chemistry. Vol. 26 (Eds. G. P. Ellis and G. B. West) pp. 437–568, Elsevier, Amsterdam 1989.
R. J. Cousins and M. R. Swerdel,Ceruloplasmin and metallothionein induction by zinc and 13-cisretinoic acid in rats with adjuvant inflammation. Proc. Soc. Exp. Biol. Med.179, 168–172 (1985).
A. Frigo, L. M. Bambara, E. Concari, M. Marrella, U. Moretti, C. Tambalo, G. P. Velo and R. Milamino,Concerning the potential therapeutic value of zinc in rheumatoid and psoriatic arthritis. InCopper and Zinc in Inflammation. (Eds. R. Milanino, K. D. Rainsford and G. P. Velo) pp. 133–142, Kluwer, Dordrecht 1989.
M. W. Whitehouse, K. D. Rainsford, R. M. Taylor and B. Vernon-Roberts,Zinc monoglycerolate: a slow-release source of zinc with anti-arthritic activity in rats. Agents and Actions31, 47–58 (1990).
R. Milanino, K. D. Rainsford and G. P. Velo (Eds.)Copper and Zinc in Inflammation. Kluwer, Dordrecht 1989.
L. M. Kelvay,An appraisal of current human copper nutrition. InInflammatory Diseases and Copper (Ed. J. R. J. Sorenson) pp. 123–132, Humana Press, Clifton, NJ 1982.
K. D. Rainsford,Environmental metal ion perturbations, especially as they affect copper status, are a factor in the etiology of arthritic conditions: An hypothesis. InInflammatory Diseases and Copper. (Ed. J. R. J. Sorenson) pp. 137–143, Humana Press, Clifton, NJ 1982.
P. A. Simkin,Oral zinc sulphate in rheumatoid arthritis. Lancet11, 539–542 (1976).
M. C. Powanda,The role of leukocytes endogeneous mediator (endogenous pyrogen) in inflammation.In Inflammatory Diseases and Copper. (Ed. J. R. J. Sorenson) pp. 31–40, Humana Press, Clifton NJ 1982.
R. Milanino, A. Conforti, L. Franco, M. Marrella and G. P. Velo,Copper and inflammation—a possible rationale for the pharmacological manipulation of inflammatory disorders. Agents and Actions16, 504–513 (1985).
R. Milanino, A. Cassini, A. Conforti, L. Franco, M. Marrella, U. Moretti and G. P. Velo,Copper and zinc status during acute inflammation: studies on blood, liver and kidneys metal levels in normal and inflamed rats. Agents and Actions19, 215–223 (1986).
D. S. Karabelas,Copper metabolism in the adjuvant-induced arthritic rat. Dissertation, University Microfilms Ann Arbor, MI, Order No 72-31,092. Diss. Abstr. Int. B 1972 33(6), 2776 (1972).
V. Kishore,Effects of adjuvant arthritis on copper, zinc, and iron metabolism in the rat. Res. Commun. Chem. Pathol. Pharmacol.63, 153–156 (1989).
V. Kishore, N. Latman, D. W. Roberts, J. B. Barnett and J. R. J. Sorenson,Effect of nutritional copper deficiency on adjuvant arthritis and immunocompetence in the rat. Agents and Actions14, 274–282 (1984).
R. Milanino, U. Moretti, E. Concari, M. Marrella and G. P. Velo,Copper and zinc status in adjuvant arthritic rat: Studies on blood, liver, kidneys, spleen and inflamed paws. Agents and Actions24, 365–376 (1988).
J. Néve, J. Fontaine, A. Peretz and J. P. Famey,Changes in zinc, copper and selenium status during adjuvant-induced arthritis in rats. Agents and Actions25, 146–155 (1988).
J. C. Oliva, M. Castell, J. Queralt and C. Castellotte,Effect of chronic inflammation on copper and zinc metabolism. Rev. Esp. Fisiol.43, 25–31 (1987).
A. Koj,Acute-phase reactants and lysosomal enzymes in the blood of rats with experimental inflammation or radiation injury. Folia Biologica18, 274–286 (1970).
A. Marusic, K. Kos, A. Stavljenic and S. Vukicevic,Acute zinc deficiency and trabecular bone loss in rats with talc granulomatosis. Biol. Trace Element Res.29, 165–173 (1991).
R. Milanino, M. Marrella, U. Moretti, E. Concari and G. P. Velo,Copper and zinc status in rats with acute inflammation: focus on the inflamed area. Agents and Actions24, 356–364 (1988).
R. S. Pekarek and G. L. Evans,Effect of acute infection and edotoxemia on zinc absorption in the rat. Proc. Soc. Exp. Biol. Med.150, 755–758 (1975).
M. C. Powanda, G. L. Cockerell and R. S. Pekarek,Amino acid and zinc movement in relation to protein synthesis early in inflammation. Am. J. Physiol.225, 339–401 (1973).
P. Z. Sobocinski, W. J. Canterbury Jr., E. C. Hauer and F. A. Beall,Induction of hypozincemia and hepatic metallothionein synthesis in hypersensitivity reactions. Proc. Soc. Biol. Med.160, 175–179 (1979).
H. J. Thompson, P. Griminger and J. L. Evans,Apparent increase in the requirement of trace minerals subsequent to severe trauma. Fed. Proc.35, 343 (Abstr. 767) (1976).
M. M. Wintrobe, G. E. Cartwright and C. J. Gubler,Studies on the function and metabolism of copper. J. Nutr.50, 395–419 (1953).
B. F. Feldman, C. L. Keen, J. J. Kaneko and T. B. Farver,Anemia of inflammatory disease in the dog: Measurement of hepatic superoxide dismutase, hepatic nonheme iron, copper, zinc, and ceruloplasmin and serum iron, copper, and zinc. Am. J. Vet. Res.42, 1114–1117 (1981).
G. L. Fisher,Effects of disease on serum copper and zinc. Values in the beagle. Am. J. Vet. Res.38, 935–940 (1977).
K. Ganrot,Plasma protein response in experimental inflammation in the dog. Res. Exp. Med.161, 251–261 (1973).
T. Bieganski, M. Z. Blasinska and J. Kusche,Determination of histaminase (diamine oxidase) activity by o-dianisine test: Interference of ceruloplasmin. Agents and Action7, 85–92 (1977).
M. C. McGahan,Copper and aspirin treatment increase the antioxidant activity of plasma. Agents and Actions31, 59–64 (1990).
M. C. McGahan, L. N. Fleisherand A. M. Grimes,Effects of copper depletion and D-penicillamine treatment on the ocular inflammatory response. Agents and Actions34, 405–409 (1991).
M. Podhradska, D. Podhradsky and J. Andrisina,Effect of inflammation on serum glycoproteins in rabbit. Folia Biologica22, 312–319 (1976).
S. C. Sweeney,Alterations in tissue and serum ceruloplasmin concentration associated with inflammation. J. Dental. Res.46 1171–1176 (1967).
B. F. Feldman, J. J. Kaneko and T. B. Farver,Anemia of inflammatory disease in the dog: Clinical characterization. Am. J. Vet. Res.42, 1109–1113 (1981).
V. Kishore, V. Boutte and L. Fourcade,Nutritional copper deficiency does not affect sponge granuloma formation in the rat. Biol. Trace Element Res.25, 115–122 (1990).
A. Conforti, L. Franco, R. Milanino and G. P. Velo,Copper and ceruloplasmin (Cp) concentrations during the acute inflammatory process in the rat. Agents and Actions12, 303–307 (1982).
P. C. Freeman and P. O'Callaghan,Decreased biovailable copper in rat and human arthritic plasma. A rationale for copper therapy. Br. J. Pharmacol.90 (Proc. Suppl.), 49P (1987).
R. Milanino, A. Conforti, M. E. Fracasso, L. Franco, R. Leone, E. Passarella, G. Tarter and G. P. Velo,Concerning the role of endogenous copper in the acute inflammatory process. Agents and actions9, 581–588 (1979).
R. Milanino, E. Passarella and G. P. Velo,Adjuvant arthritis in young copper-deficient rats. Agents and Actions8, 623–628 (1978).
R. Milanino, A. Frigo, L. M. Bambara, M. Marrella, U. Moretti, M. Pasqualicchio, D. Biasi, R. Gasperini, L. Mainenti and G. P. Velo,Copper and zinc status in rheumatoid arthritis: Studies on plasma, erythrocytes, and urine, and relationship with disease activity markers and pharmacological treatment. Clin. Exp. Rheumatol. (in press).
M. Webb and K. Cain,Functions of metallothionein. Biochem. Pharmacol.31, 137–142 (1982).
A. Conforti, L. Franco, R. Milanino, A. Totorizzo and G. P. Velo,Copper metabolism during acute inflammation: Studies on liver and serum copper concentrations in normal and inflamed rats. Br. J. Pharmacol.79, 45–52 (1983).
V. Albergoni, A. Cassini, N. Favero and G. P. Rocco,Effect of penicillamine on some metals and metalloproteins in the rat. Biochem. Pharmacol.24, 1131–1133, (1975).
V. Kishore,Effects of copper aspirinate and aspirin on tissue copper, zinc, and iron concentrations following chronic oral treatment in the adjuvant arthritic rat. Biol. Trace Element Res.25, 123–135 (1990).
J. Aaseth, E. Munthe, O. Forre and E. Steinnes,Trace elements in serum and urine of patients with rheumatoid arthritis. Scand. J. Rheumatol.7, 237–240 (1978).
M. C. Bacon, P. H. White, D. J. Raiten, N. Craft, S. Margolis, O. A. Levander, M. L. Taylor, R. L. Lipnick and S. Sami,Nutritional status and growth in juvenile rheumatoid arthritis. Seminars Arth. Rheum.20, 97–106 (1990).
D. P. Bajpayee,Significance of plasma copper and caeruloplasmin concentrations in rheumatoid arthritis. Ann. Rheum. Dis.34, 162–165 (1975).
Z. Balogh, A. F. El-Ghobarey, G. S. Fell, D. H. Brown, J. Dunlop and G. S. Dick,Plasma zinc and its relationship to clinical symptoms and drug treatment in rheumatoid arthritis. Ann. Rheum. Dis.39, 329–332 (1980)
J. C. Banford, D. H. Brown, R. A. Hazelton, C. J. Mc Neil, R. D. Sturrock and W. E. Smith,Serum copper and erythrocyte superoxide dismutase in rheumatoid arthritis. Ann. Rheum. Dis.41, 458–462 (1982).
R. A. Bonnebrake, J. T. McCall, G. G. Hunder and H. F. Polley,Zinc accumulation in synovial fluid. Mayo clin. Proc.47, 746–750 (1972).
M. E. Lahey, C. J. Gubler, G. E. Cartwrightand M. M. Wintrobe,Studies on copper metabolism—VII—Blood copper in pregnancy and various pathological states. J. Clin. Invest.32, 329–337 (1953).
U. Moretti, A. Frigo, M. Marrella, G. P. Velo, C. Tambalo, L. M. Bambara and R. Milanino,Copper and zinc in plasma, blood cells and urine of rheumatoid patients. Pharmacol. Res. Commun.20 (suppl. 1) 19–20 (1988).
H. Mussalo-Rauhamaa, Y. T. Konttinen, J. Lehto and V. Honkanen,Predictive clinical and laboratory parameters for serum zinc and copper in rheumatoid arthritis. Ann. Rheum. Dis.47, 816–819 (1988).
A. Peretz, J. Nève and J. P. Famaey,Effects of chronic and acute corticosteroid therapy on zinc and copper status in rheumatoid arthritis patients. J. Trace Element Electrolytes Health. Dis.3, 103–108 (1989).
A. Peretz, J. Nève, F. Vertongen and J. P. Famaey,Synovial fluid copper, zinc and selenium in relation to inflammatory parameters in rheumatic diseases. InBiology of Copper Complexes (Ed. J. R. J. Sorenson) pp. 583–589, Humana Press, Clifton, NJ 1987.
W. Pruzanski, M. L. Russel, D. A. Gordon and M. A. Ogryzlo,Serum and synovial fluid proteins in rheumatoid arthritis and degenerative joint diseases. Am. J. Med. Sci.265, 483–490 (1973).
P. R. Scudder, W. McMurray, A. G. White and T. L. Dormandy,Synovial fluid copper and related variables in rheumatoid and degenerative arthritis. Ann. Rheum. Dis.37, 71–72 (1978).
K. L. G. Svenson, R. Hallgren, E. Johansson and U. Lindh,Reduced zinc in peripheral blood cells from patients with inflammatory connective tissue diseases. Inflammation9, 189–199 (1976).
M. I. V. Jayson, P. Davis, J. T. Whitcherand G. Walters,Serum copper and caeruloplasmin in ankylosing spondylitis, systemic sclerosis, and morphea. Ann. Rheum. Dis.35, 443–445 (1976).
L. Mataran-Perez, J. Gonzalez-Dominguez, M. Rodriguez-Perez, D. Rodrigo, M. Abellen-Perez and D. Salvatierra-Rios,Plasma and intraerythrocytic zinc in rheumatoid arthritis and ankylosing spondylitis. Ann. Intern. Med.6, 629–632 (1989).
J. R. J. Sorenson,Mean serum copper, magnesium and zinc concentrations in active rheumatoid and other degenerative connective tissue diseases. InTrace Substances in Environmental Health, Vol. 11 (Ed. D. D. Hemphill) pp. 15–22, University of Missouri, Columbia, MO 1977.
J. H. Freeland, R. Schwartz, R. J. Cousins and A. C. Burkart,Peridontal disease: Relationship of trace element status. Fed. Proc.35, 262 (Abstr. 314) (1976).
C. C. Ainley, J. Cason, L. K. Carlsson, B. M. Slavin and R. P. H. Thompson,Zinc status in inflammatory bowel disease. Clin. Sci.75, 277–283 (1988).
N. A. Kryukova,Index of inhibition of ceruloplasmin activity under the effect of ascorbic acid in vitro, in acute inflammatory process. Lab. Delo31, 153–156 (1972).
L. Matarn-Perez, M. Rodriguez-Perez, J. Gonzalez-Dominguez, D. Rodrigo, A Gonzalez-Utrilla, M. Abellan-Perez and D. Salvatierra-Rios,Zinc in arthrosis and microcrystalline arthritis. Rev. Clin. Esp. 60–62 (1991).
G. Michaelson and K. Ljunghall,Patients with dermatitis herpetiformis, acne psoriasis and Darier's disease have low epidermal zinc concentrations. Acta Derm. Venereol.70, 304–308 (1990).
R. S. Pekarek and W. R. Beisel,Redistribution and sequestering of essential trace elements during acute infection. InProc. IX Int. Congr. Nutrition, Mexico, 1972, Vol. 2, pp. 193–198. Karger, Basel 1975.
P. R. Scudder, D. Al-Timini, W. McMurray, A. G. White, B. C. Zoob and T. L. Dormandy,Serum copper and related variables in rheumatoid arthritis. Ann. Rheum. Dis.37, 67–70 (1978).
A. Conforti, L. Franco, G. Menegale, R. Milanino, G. Piemonte and G. P. Velo,Serum copper and ceruloplasmin levels in rheumatoid arthritis and degenerative joint disease and their pharmacological implications. Pharmacol. Res. Commun.15, 859–867 (1983).
H. Hyora, A-L. Makela, P. Pakarinen, T. Bergman and V. Nanto,Trace elements (copper, zinc and iron) in serum of rheumatic children living in south-western Finland. Acta Pharmacol. Toxicol.59 (Suppl. 7), 403–405 (1986).
A. Lorber, L. S. Cutler and C. C. ChangSerum copper levels in rheumatoid arthritis: Relationship of elevated copper to protein alteration. Arch. Rheum.11, 65–71 (1968).
D. H. Brown, W. W. Buchanan, A. F. El-Gobarey, W. E. Smith and J. Teape,Serum copper and its relationship to clinical symptoms in rheumatoid arthritis. Ann. Rheum. Dis.38, 174–176 (1979).
A. A. R. Youssef, B. Wood and D. N. Baron,Serum copper: A marker of disease activity in rheumatoid arthritis. J. Clin. Pathol.36, 14–17 (1983).
V. Honkanen, P. Pelkonen, H. Mussalo-Rauhamaa, J. Lehto and T. Westermarck,Serum trace elements in juvenile chronic arthritis. Clin. Rheumatol.8, 64–70 (1989).
R. Milanino, S. Mazzoli, E. Passarella, G. Tarter and G. P. Velo,Carrageenan oedema in copper deficient rats. Agents and Actions8, 618–622 (1978).
N. W. Solomons,Zinc and copper in human nutrition. InZinc and Copper in Medicine. (Eds. Z. A. Kargiogu and R. M. Sarper) pp. 224–275, Charles C. Thomas, Springfield, IL 1980.
R. J. Cousins,Absorption, transport, and hepatic metabolism of copper and zinc: Special reference to metallothionein and ceruloplasmin. Physiol. Rev.65, 238–309 (1985).
R. A. Di Silvestro and R. J. Cousins,Physiological ligands for. copper and zinc. Annu. Rev. Nutr.3, 261–288 (1983).
R. M. Russel,Vitamin A and zinc metabolism in alcoholism. Am. J. Clin. Nutr.33, 2741–2749 (1980).
J. W. Foote and H. T. Delves, Albumin bound and α2-macroglobulin bound zinc concentrations in the sera of healthy adults.. J. Clin. Pathol.37, 1050–1054 (1984).
A. S. Prasad,Deficiency of zinc in man and its toxicity. InTrace Elements in Human Health and Disease (Ed. A. S. Prasad) pp. 1–20, Academic Press, New York 1976.
A. S. Prasad,The role of zinc in gastrointestinal and liver disease. InClinics in Gastroenterology (Ed. M. S. Losowsky) pp. 713–741, Saunders, London 1983.
J. Patrick and C. Dervish,Leukocyte zinc in the assessment of zinc status. Crit. Rev. Lab. Sci.20, 95–114, (1984).
W. A. Briggs, M. M. Pedersen, S. K. Mahajan, D. H. Sillix, A. S. Prasad and F. D. McDonald,Lymphocyte and granulocyte function in zinc-treated and zinc-deficient hemodialysis patients. Kidney Int.21, 827–832 (1982).
S. Bro, M. Stokholm and P. J. Jørgensen,Zinc in mononuclear leucocytes in alcoholics with liver cirrhosis or chronic pancreatitis and in patients with Crohn's disease before and after zinc supplementation. J. Trace. Element Electrolytes Health Dis.3, 243–248 (1989).
A. Peretz, J. Nève, O. Jechers, N. Leclercq., J.-P. Praet, F. Vertongen and J.-P. Famaey,Interest of zinc determination in leucocyte fractions for the assessment of marginal zinc status. Clin. Chim. Acta203, 35–46 (1991).
H. Elling, S. Kiilerich, C. Chritiansen and J. Gylding-Sabroe,The effect of indomethacin and naproxen on zinc metabolism. Scand. J. Rheumatol.7, 145–146 (1978).
M. K. Song and N. F. Adham,Role of prostaglandin E 2 in zinc absorption in the rat. Am. J. Physiol.234, E99-E105 (1978).
K. T. Smith, R. J. Cousins, B. L. Silbon and M. L. Failla,Zinc absorption and metabolism by isolated, vascularly perfused rat intestine. J. Nutr.108, 1849–1857 (1978).
J. Fontaine, J. Nève, A. Peretz, F. Pelen and J. P. Famaey,Comparison of effects of chronic inflammation and longterm prednisolone administration on zinc metabolism in rats. Int. J. Tissue React.11, 253–259 (1989).
J. M. Walshe,Penicillamine. A new oral therapy for Wilson's disease. Am. J. Med.21, 487–495 (1956).
V. Albergoni, N. Favero and G. P. Rocco,Copper metabolism in the rat: Effects of copper loading and copper depletion. Bioinorg. Chem.9, 431–440 (1978).
G. J. Brewer, G. M. Hill, A. S. Prasad, Z. T. Cossack and P. Rabbani,Oral Zinc therapy for Wilson's disease. Ann. Intern. Med.99, 314–320 (1983).
L. V. Jepsen and K. H. Pedersen,Changes in zinc and zinc-dependent enzymes in rheumatoid patients during penicillamine treatment. Scand. J. Rheumatol.13 282–288 (1984).
K. Bibow, B. Salbu, K. M. H. Strand and E. Munthe,The influence of D-penicillamine on trace element excretion. Acta Pharmacol. Toxicol.59 (Suppl. 7), 374–377 (1986).
R. P. Sharma,Metabolism of intracellular zinc and copper following single and repeated injections of gold sodium thiomalate. Agents and Actions13, 380–388 (1983).
M. Cutolo, S. Rovida, E. Samanta and S. Accardo,Effect of drugs on serum copper and its correlation with other humoral factors in rheumatoid arthritis. InInflammation: Mechanisms and Treatment. (Eds. D. A. Willoughby and J. P. Giroud) pp. 451–456, MTP Press, Lancaster 1980.
W. E. Smith, D. H. Brown, J. Dunlop, R. Hazelton, R. D. Sturrock and A. J. Lewis,The effect of therapeutic agents on serum copper levels and serum oxidase activities in the rat adjuvant model compared to analogous results from studies of rheumatoid arthritis in humans. InInflammation: Mechanisms and Treatment (Eds. D. A. Willoughby and J. P. Giroud) pp. 457–463, MTP press, Lancaster 1980.
H. Elling, S. Kiilerich, J. Sabro and P. Elling,Influence of a non-steroid antirheumatic drug on serum and urinary zinc in healthy volunteers. Scand. J. Rheumatol. 9, 161–163 (1980).
A. Peretz, J. Nève and J. P. Famaey,Zinc, copper and selenium in chronic and acute inflammatory rheumatic diseases. InTrace Element Analytical Chemistry in Medicine and Biology. (Eds. P. Bratter and P. Schramel) pp. 471–476, Walter de Gruyter, Berlin 1988.
J. Fontaine, J. Nève A. Peretz,P. Capel and J. P. Famaey,Effects of acute and chronic prednisolone treatment on serum zinc levels in rats with adjuvant arthritis. Agents and Actions33, 247–253 (1991).
G. C. Sturniolo, A. Martin, G. Gurrieri and R. Naccarato,The effects of prostaglandin synthetase inhibition on the oral zinc tolerance test in man. Gastroenterol. Clin. Biol.7, 933, (1983).
C. A. Dinarello,Interleukin-l and interleukin-l antagonism. Blood77, 1627–1652 (1991).
K. Arai, F. Lee, A. Miyajima, S. Miyatake,N. Arai and T. Yokota,Cytokines: Coordinators of immune and inflammatory responses. Annu. Rev. Biochem.59, 783–836 (1990).
I. Paegelow, H. Werner and G. Vietinghoff,The production of interleukin-l induced by an acute non-specific inflammation in mice. Agents and Actions23, 79–81 (1988).
M. Perretti, E. Solito and L. Parente,Evidence that endogenous interleukin-l is involved in leukocyte migration in acute experimental inflammation in rats and mice. Agents and Actions35, 71–78 (1992).
M. E. Davies, H. Sharma and R. Pigott,ICAM-l expression on chondrocytes in rheumatoid arthritis: induction by synovial cytokines. Mediators Inflammation1, 71–74 (1992).
Y. Iigo, T. Takashi, T. Tamatani, M. Miyasaka, T. Higashida, H. Yagita K. Okumura and W. Tsukada,ICAM-1-dependent pathway is critically involved in the pathogenesis of adjuvant arthritis in rats. J. Immunol.147, 4167–4171 (1991).
P. Z. Sobocinski, W. J. Canterbury Jr., C. A. Mapes, R. E. Dinterman, E. C. Hauer and F. B. Abeles,Hypozincemia of inflammation: Sequestration of zinc by hepatic metallothionein. Fed. Proc.37, 890 (Abstract 3558) (1978).
O. J. Hartmann, T. Schechinger and U. Weser,Copperthionein in leucocytes. Biol. Met.2, 40–44 (1989).
O. J. Mesna, I. L. Steffensen, A. Melhuus, H. Hjertholm, H. E. Heier and R. A. Andersen,Induction of metallothionein production of zinc in human mononuclear cells. Gen. Pharmacol.21, 909–917 (1990).
J. J. Schroeder and R. J. Cusins,Interleukin 6 regulates metallothionein gene expression and zinc metabolism in hepatocyte monolayer cultures. Proc. Natl. Acad. Sci. USA87, 3137–3141 (1990).
R. J. Cousins and A. S. Leinart,Tissue-specific regulation of zinc metabolism and metallothionein genes by interleukin 1. FASEB J. 2, 2884–2890 (1988).
E. J. Lewis, A. D. Sedgwick and T. H. P. Hanahoe,In Vivo changes in plasma acute phase protein levels in the rat induced by slow release of IL-1, IL-6 and TNF. Mediators Inflammation1, 39–44 (1992).
R. A. Di Silvestro and J. T. Marten,Effects of inflammation and copper intake on rat liver and erythrocyte Cu−Zn superoxide dismutase activity levels. J. Nutr.120, 1223–1227 (1990).
About this article
Cite this article
Milanino, R., Marrella, M., Gasperini, R. et al. Copper and zinc body levels in inflammation: An overview of the data obtained from animal and human studies. Agents and Actions 39, 195–209 (1993). https://doi.org/10.1007/BF01998974
- Rheumatoid Arthritis
- Inflammatory Process
- Pharmacological Property